Letter | Published:

A new class of GABA agonist

Naturevolume 268pages5355 (1977) | Download Citation



COMPOUNDS which mimic the activity of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) on postsynaptic receptors are of particular pharmacological interest as possible therapeutic agents in human neurological disorders and as molecular probes with which to study different types of GABA receptors. The GABA molecule has considerable flexibility with free rotation around all three carbon–carbon bonds as indicated in Fig. 1. This conformational mobility is reduced in GABA analogues such as trans-4-aminocrotonic acid1 and muscimol2, which are potent GABA agonists at bicuculline-sensitive receptors on spinal neurones of the cat. The conformational mobility of such compounds can be reduced still further by incorporating the amino function in a ring structure. This has led to a new class of GABA agonist described here, based on l,2,3,6-tetrahydropyridine-4-carboxylic acid (isoguvacine) and the related bicyclic isoxazole 4,5,6,7-tetra-hydroisoxazolo[5,4-c]pyridin-3-ol (THIP) (Fig. 1). Isoguvacine represents a semi-rigid analogue of trans-4-aminocrotonic acid in a folded conformation. THIP, a folded analogue of muscimol, is even more rigid as the ‘masked’ carboxyl group (the 3-isoxazolo moiety) is fixed in the general plane of the molecule. The action of these compounds as GABA agonists provides indirect evidence that GABA interacts with bicuculline-sensitive postsynaptic receptors in the cat spinal cord in a partially extended and almost planar conformation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Johnston, G. A. R., Curtis, D. R., Beart, P. M., Game, C. J. A., McCulloch, R. M. & Twitchin, B. J. Neurochem. 24, 157–160 (1975).

  2. 2

    Curtis, D. R., Duggan, A. W., Felix, D. & Johnston, G. A. R. Brain Res. 32, 69–96 (1971).

  3. 3

    Beart, P. M., Johnston, G. A. R. & Uhr, M. L. J. Neurochem. 19, 1855–1861 (1972).

  4. 4

    Beart, P. M., Uhr, M. L. & Johnston, G. A. R. J. Neurochem. 19, 1849–1854 (1972).

  5. 5

    Krogsgaard-Larsen, P. & Christensen, S. B. Acta chem. scand. B 30, 281–282 (1976).

  6. 6

    Johnston, G. A. R. et al. Nature new Biol. 240, 219–220 (1972).

  7. 7

    Krogsgaard-Larsen, P. & Johnston, G. A. R. J. Neurochem. 25, 797–802 (1975).

  8. 8

    Johnston, G. A. R., Krogsgaard-Larsen, P. & Stephanson, A. Nature, 258, 627–628 (1975).

  9. 9

    Lodge, D., Johnston, G. A. R., Curtis, D. R. & Brand, S. J. Brain Res. (in the press).

  10. 10

    Krogsgaard-Larsen, P., Johnston, G. A. R., Curtis, D. R., Game, C. J. A. & McCulloch, R. M. J. Neurochem. 25, 803–809 (1975).

Download references

Author information


  1. Department of Pharmacology, Australian National University, Canberra, Australia

    • , G. A. R. JOHNSTON
    • , D. LODGE
    •  & D. R. CURTIS
  2. Department of Chemistry BC, Royal Danish School of Pharmacy, Copenhagen, Denmark

    • , G. A. R. JOHNSTON
    • , D. LODGE
    •  & D. R. CURTIS


  1. Search for P. KROGSGAARD-LARSEN in:

  2. Search for G. A. R. JOHNSTON in:

  3. Search for D. LODGE in:

  4. Search for D. R. CURTIS in:

About this article

Publication history



Issue Date



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.